117 related articles for article (PubMed ID: 30165631)
1. Tumor bleeding requiring intervention and the correlation with anemia in uterine cervical cancer for definitive radiotherapy.
Yanazume S; Karakida N; Higashi R; Fukuda M; Togami S; Kamio M; Ota S; Kobayashi H
Jpn J Clin Oncol; 2018 Oct; 48(10):892-899. PubMed ID: 30165631
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
[TBL] [Abstract][Full Text] [Related]
4. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
[TBL] [Abstract][Full Text] [Related]
5. The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy.
Matsumoto Y; Mabuchi S; Kozasa K; Kuroda H; Sasano T; Yokoi E; Komura N; Sawada K; Kimura T
Gynecol Oncol; 2017 Jun; 145(3):469-475. PubMed ID: 28552395
[TBL] [Abstract][Full Text] [Related]
6. Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study.
Taguchi A; Furusawa A; Ito K; Nakajima Y; Shimizuguchi T; Hara K; Takao M; Kashiyama T; Kino N; Karasawa K; Yasugi T
Int J Clin Oncol; 2020 May; 25(5):955-962. PubMed ID: 31960184
[TBL] [Abstract][Full Text] [Related]
7. [Anemia impact on treatments of cervical carcinomas].
Marchal C; Rangeard L; Brunaud C
Cancer Radiother; 2005 Mar; 9(2):87-95. PubMed ID: 15820436
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy.
Serkies K; Badzio A; Jassem J
Acta Oncol; 2006; 45(6):695-701. PubMed ID: 16938812
[TBL] [Abstract][Full Text] [Related]
9. Tumor hypoxia, p53, and prognosis in cervical cancers.
Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
[TBL] [Abstract][Full Text] [Related]
10. Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy.
Narayan K; Fisher R; Bernshaw D
Int J Gynecol Cancer; 2006; 16(2):623-30. PubMed ID: 16681737
[TBL] [Abstract][Full Text] [Related]
11. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
Torbé B
Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy.
Kapp KS; Poschauko J; Geyer E; Berghold A; Oechs AC; Petru E; Lahousen M; Kapp DS
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):58-66. PubMed ID: 12182975
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of anemia for patients with cervical cancer treated with irradiation].
Grigiene R; Aleknavicius E; Kurtinaitis J
Medicina (Kaunas); 2005; 41(11):916-24. PubMed ID: 16333214
[TBL] [Abstract][Full Text] [Related]
14. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.
Dunst J; Kuhnt T; Strauss HG; Krause U; Pelz T; Koelbl H; Haensgen G
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):778-87. PubMed ID: 12788185
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
[TBL] [Abstract][Full Text] [Related]
16. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
17. Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.
Chai Y; Wang T; Wang J; Yang Y; Gao Y; Gao J; Gao S; Wang Y; Zhou X; Liu Z
BMC Cancer; 2014 Feb; 14():63. PubMed ID: 24495453
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and outcome of cervical cancer in national institute of Morocco.
Elmajjaoui S; Ismaili N; El Kacemi H; Kebdani T; Sifat H; Benjaafar N
BMC Womens Health; 2016 Sep; 16(1):62. PubMed ID: 27618814
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
